Protective Effects of At1-Receptor Blocker and Ca Antagonist Combination on Renal Function in Salt Loaded Spontaneously Hypertensive Rats/ Протективни Ефекти На Комбинацијата На Ат1 Рецепторен Блокатор И Калциум Антагонист Врз Реналната Функција Кај Спонтано Хипертензивни Стаорци Оптоварени Со Сол


Salt sensitive hypertension is known to be a contributing factor for the progression of kidney disease. This study was undertaken to investigate the role of excessive dietary salt on renal function and to evaluate the effect of valsartan and amlodipin given as a combination therapy on blood pressure and parameters specific to the renal function in salt loaded SHR rats. 48 male SHR rats at age of 20 weeks and body weight ranging between 270-350 g were used. SHR rats were divided into 3 groups: control group of rats -SHRC (n = 16) given tab water ad libitum and two salt treated groups in which tab water was replaced with a solution of NaCl (1%) from age of 8 weeks given ad libitum: SHRVAL+AMLO group (n = 16) where investigated drugs were administered at a dose of 10 mg/kg/ b.w. (valsartan) and 5 mg/kg/ b.w. (amlodipin) by gavage and SHR NaCl group (n = 16) that received saline in the same volume and the same time intervals as the SHRVAL+AMLO group. For a period of 12 weeks we have investigated the effect of the VAL+AMLO drug combination on systolic blood pressure (SBP), body weight and renal function tests. Salt loading with 1% solution in the SHR NaCl group has lead to significant increase of blood pressure, proteinuria and decrease in creatinine clearance. Combined treatment with АТ1-receptor blocker and calcium antagonist has managed to control blood pressure and ameliorated renal damage.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Campese VM. Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension. 1994; 23: 531-50.

  • 2. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996; 334: 13-18.

  • 3. Frohlich E.D. The Salt Cohondrum A Hypothesis. Hypertension. 2007; 50: 161-6.

  • 4. Laverman GD, Remuzzi G, Ruggenenti P.ACE inhibition versus angiotensin receptor blockade: which is better for renal and cardiovascular protection. J Amer Soc Nephrol. 2004; 15: S64-S70.

  • 5. Berl T. Angiotensin-converting enzyme inhibitors versus AT1 antagonist in cardiovascular and renal protection: the case for AT1 receptor antagonist. J Amer Soc Nephrol. 2004; 15: S71-S76.

  • 6. Boffa J. Lu Y, Placier A, Stefanski A, Dussaule J, Chatziantoniou C. Reggression of renal and glomerular fibrosis: the rose of angiotensin IIreceptor antagonism andmatrix metalloproteinases. J Amer Soc Nephrol. 2003; 14: 1132-1144.

  • 7. Trippodo N.C, Frohlich E.D. Similarities of genetic (spontaneous) hypertension.Man and rat. Circ Res. 1981; 48: 309-19.

  • 8. Doggrell S.A, Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovascular Research. 1998; 39: 89-105.

  • 9. Field LG, Van Liew JB, Galaske RG, Boylan JW, Chang H, Manz N, Muir P. Selectivity of renal injury and proteinuria in the spontaneously hypertensive rat. Kidney International. 1977; 12: 332-43.

  • 10. Katori M, Majima M. A missing link between a high salt intake and blood pressure increase. J Pharmacol Sci. 2006; 100: 370-90.

  • 11. Susic D, Fares H, Frohlich E.D. Salt, Arterial pressure and cardiovascular and renal damage. Ochsner Journal. 2009; 9: 197-203.

  • 12. Yuan B, Leenen FHH. Dietary sodium intake and left ventricular hypertrophy in normotensive rats.Am J Physiol Heart Circ Physiol. 1991; 261: H1397- H1401.

  • 13. Meulemans D. Determination of total protein in spinal fluid with sulphosalycilic acid and trichloroacetate. Clin Chim Acta. 1961; 5: 757-61.

  • 14. Bartels H and Bohmer M. Serum creatinine determination without protein precipitation. Clin Chim Acta. 1972; 37: 193-97.

  • 15. The effects of nonpharmacological interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I [published correction appears in JAMA. 1992; 267(17): 2330]. JAMA 1992. 267 (9): 1213-1220.

  • 16. Trials of Hypertension Prevention Collaborative Research Group Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with highnormal blood pressure: the Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997; 157 (6): 657-67.

  • 17. Bray GA, Vollmer WM, Sacks FM, Obarzanek E, Svetkey LP, Appel LJ. DASH Collaborative Research Group A further subgroup analysis of the effects of DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial. Am J Cardiol. 2004. 94 (2): 222-227.

  • 18. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001; 344 (1): 3-10.

  • 19. Hooper L, Bartlett C, Davey Smith S, Ebrahim S. Systematic review of long-term effects of advice to reduce dietary salt in adults. BMJ. 2002; 325(7365): e628.

  • 20. Chrysant SG, Walsh GM, Frohlich ED. Hemodynamic changes induced by prolonged NaCl and DOCA administration in spontaneously hypertensive rats. Angiology. 1978; 29: 303-309.

  • 21. Chrysant SG, Walsh GM, Kem DC, Frohlich ED. Hemodynamic and metabolic evidence of salt sensitivity in spontaneously hypertensive rats. Kidney Int’l. 1979; 15: 33-37.

  • 22. Frohlich ED, Chien Y, Sesoko S, Pegram BL. Relationship between dietary sodium intake, hemodynamics, and cardiac mass in SHR and WKY rats. Am J Physiol. (Regulatory Integrative 33). 1993; 264: R30-R34.

  • 23. Varagic J, Frohlich E.D, Diez J, Susic D, Ahn J, Gonsales A, Lopez B. Myocardial fibrosis, impared coronary hemodynamics and biventricular dysfunction in salt-loaded SHR.Am J Physiol Heart Cir Physiool. 2006; 290: H1503-1509.

  • 24. Limas C, Westrum B, Limas C.J, Cohn J.N. Effect of Salt on Vascular Lesions of Spontaneously Hypertensive Rats. Hypertension. 1980; 2: 477-89.

  • 25. Cavanagh EM, Ferder LF, Ferder MD, Stella IY, Toblli JE, Inserra F. Vascular structure and oxidative stress in salt-loaded spontaneously hypertensive rats: effects of losartan and atenolol. Am J Hypertens. 2010; 23(12): 1318-25.

  • 26. Matavelli LC, Zhou X, Varagic J, Susic D, Frohlich ED. High-salt diet produces severe renal dysfunction independently of changes in arterial pressure in spontaneously hypertensive rats (SHR). Am J Physiol Heart, Circ Physiol. 2007; 292: H814-H819.

  • 27. Navar LG, Prieto-Carrasquero MC, Kobori H. Regulation of renin in JGA and tubules in hypertension. In: The Local Cardiac Renin AngiotensinAldosterone System, edited by Frohlich ED and Re RN. New York: Springer Science and Business Media. 2006; p. 45-59.

  • 28. Nickenig G, Strehlow K, Roeling J, Zolk O, Knorr A, Bohm M. Salt induces AT1 receptor overexpression in vitro and in vivo.Hypertension. 1998; 31: 1272-77.

  • 29. Schunkert H, Ingelfinger JR, Jacob H, Jackson B, Bouyounes B, Dzau VJ. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol Endocrinol Metab. 1992; 263: E863-E869.

  • 30. Thomson SC, Deng A, Wead L, Richter K, Blantz RC, Vallon V. An unexpected role for angiotensin II in the link between dietary salt and proximal reabsorption. J Clin Invest. 2006; 116: 1110-116.

  • 31. Varagic J. Salt-loading: a paradigm for a local cardiac renin-angiotensinaldosterone system. In: The Local Cardiac Renin Angiotensin-Aldosterone System, edited by Frohlich ED and Re RN. New York: Springer Science and Business Media. 2006; p. 61-72.

  • 32. Susic D, Frohlich E.D. Telmisartan improves survival and ventricular function in SHR rats with extensive cardiovascular damage induced by dietary salt excess. J Am Soc Hypertens. 2014; 8 (5): 297-302.


Journal + Issues